Cell & Gene Therapy World Asia 2026 (Biopharma in Asia outside SG)

Since 2017, Cell & Gene Therapy World Asia has witnessed huge success in bringing over 300 industry pioneers from both cell & gene therapy industry. With the mission to facilitate the research & development and manufacturing of high quality cell & gene therapy treatments and regenerative medicines in Asia, Cell & Gene Therapy World Asia 2026 is going to continue its legacy.

In addition, this year, speakers will be exploring innovations in cell & gene therapy in Asia region, best practices on cell & gene therapy manufacturing and process development, scale out strategies, cost optimization, next generation on CART, advances in CART manufacturing, preparation for commercialization, regulation case studies and more.

Join the conference to interact with key and upcoming entities from Asia cell & gene therapy companies including BeiGene, Gracell Biotechnologies, Fosun Kite Biotechnology, Tessa Therapeutics, CARSgen, Senlang Bio, Kangstem Biotech, Medigen Biotechnology Corp, Shangai UniCAR Therapy among others.

Catch the latest cell & gene therapy development in Asia. From current best R&D practices to advancing towards manufacturing and commercialization from most-exclusive case studies to industry's key needs. All this and more under 1 roof.

Group Booking Discounts:

Buy 3 get 10% off, Buy 5 get 20% off, Buy 6 or more get 25% off
*Contact your Sales/Marketing Representative for discount availablity